Koninklijke Philips N.V. (PHG)
USD 24.71
(-1.2%)
USD 24.71
(-1.2%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.49 Billion EUR | -13.78% |
| 2022 | 4.04 Billion EUR | 17.36% |
| 2021 | 3.45 Billion EUR | 15.27% |
| 2020 | 2.99 Billion EUR | 7.93% |
| 2019 | 2.77 Billion EUR | 3.7% |
| 2018 | 2.67 Billion EUR | 13.64% |
| 2017 | 2.35 Billion EUR | -30.63% |
| 2016 | 3.39 Billion EUR | -2.05% |
| 2015 | 3.46 Billion EUR | 4.5% |
| 2014 | 3.31 Billion EUR | 2.28% |
| 2013 | 3.24 Billion EUR | -7.3% |
| 2012 | 3.49 Billion EUR | -3.59% |
| 2011 | 3.62 Billion EUR | -6.21% |
| 2010 | 3.86 Billion EUR | 32.68% |
| 2009 | 2.91 Billion EUR | -13.59% |
| 2008 | 3.37 Billion EUR | 5.09% |
| 2007 | 3.2 Billion EUR | 11.38% |
| 2006 | 2.87 Billion EUR | -17.19% |
| 2005 | 3.47 Billion EUR | 7.76% |
| 2004 | 3.22 Billion EUR | 0.91% |
| 2003 | 3.19 Billion EUR | -9.27% |
| 2002 | 3.52 Billion EUR | -17.98% |
| 2001 | 4.29 Billion EUR | -18.82% |
| 2000 | 5.29 Billion EUR | 15.6% |
| 1999 | 4.57 Billion EUR | 7.74% |
| 1998 | 4.25 Billion EUR | -17.06% |
| 1997 | 5.12 Billion EUR | 3.19% |
| 1996 | 4.96 Billion EUR | -15.61% |
| 1995 | 5.88 Billion EUR | 19.95% |
| 1994 | 4.9 Billion EUR | 9.84% |
| 1993 | 4.46 Billion EUR | -6.48% |
| 1992 | 4.77 Billion EUR | 4.83% |
| 1991 | 4.55 Billion EUR | -8.97% |
| 1990 | 5 Billion EUR | -11.72% |
| 1989 | 5.66 Billion EUR | 5.34% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 3.61 Billion EUR | 0.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q3 | - EUR | -100.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q4 | 3.49 Billion EUR | 0.0% |
| 2023 Q2 | 4.09 Billion EUR | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 FY | 3.49 Billion EUR | -13.78% |
| 2022 Q2 | 4.1 Billion EUR | 0.0% |
| 2022 Q4 | 4.04 Billion EUR | 0.0% |
| 2022 FY | 4.04 Billion EUR | 17.36% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2021 Q2 | 3.22 Billion EUR | 0.0% |
| 2021 Q4 | 3.45 Billion EUR | 0.0% |
| 2021 FY | 3.45 Billion EUR | 15.27% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2020 Q2 | 3.19 Billion EUR | 0.0% |
| 2020 Q4 | 2.99 Billion EUR | 0.0% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 FY | 2.99 Billion EUR | 7.93% |
| 2020 Q3 | - EUR | -100.0% |
| 2019 Q4 | 2.77 Billion EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | 2.98 Billion EUR | 0.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 FY | 2.77 Billion EUR | 3.7% |
| 2018 Q2 | 2.7 Billion EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q4 | 2.67 Billion EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 FY | 2.67 Billion EUR | 13.64% |
| 2017 Q4 | 2.35 Billion EUR | -12.56% |
| 2017 FY | 2.35 Billion EUR | -30.63% |
| 2017 Q1 | 3.62 Billion EUR | 6.99% |
| 2017 Q2 | 2.56 Billion EUR | -29.35% |
| 2017 Q3 | 2.69 Billion EUR | 4.95% |
| 2016 Q3 | 3.75 Billion EUR | 1.93% |
| 2016 Q1 | 3.6 Billion EUR | 3.98% |
| 2016 Q2 | 3.68 Billion EUR | 2.42% |
| 2016 Q4 | 3.39 Billion EUR | -9.76% |
| 2016 FY | 3.39 Billion EUR | -2.05% |
| 2015 Q3 | 4.01 Billion EUR | 0.96% |
| 2015 Q1 | 3.91 Billion EUR | 18.17% |
| 2015 Q4 | 3.46 Billion EUR | -13.66% |
| 2015 FY | 3.46 Billion EUR | 4.5% |
| 2015 Q2 | 3.97 Billion EUR | 1.46% |
| 2014 Q1 | 3.44 Billion EUR | 6.45% |
| 2014 Q4 | 3.31 Billion EUR | -16.71% |
| 2014 Q3 | 3.97 Billion EUR | 9.37% |
| 2014 Q2 | 3.63 Billion EUR | 5.48% |
| 2014 FY | 3.31 Billion EUR | 2.28% |
| 2013 Q1 | 3.63 Billion EUR | 3.89% |
| 2013 FY | 3.24 Billion EUR | -7.3% |
| 2013 Q2 | 3.69 Billion EUR | 1.87% |
| 2013 Q4 | 3.24 Billion EUR | -15.45% |
| 2013 Q3 | 3.83 Billion EUR | 3.6% |
| 2012 Q1 | 3.81 Billion EUR | 5.35% |
| 2012 Q2 | 3.97 Billion EUR | 4.03% |
| 2012 FY | 3.49 Billion EUR | -3.59% |
| 2012 Q4 | 3.49 Billion EUR | -14.15% |
| 2012 Q3 | 4.07 Billion EUR | 2.47% |
| 2011 Q1 | 3.54 Billion EUR | -8.28% |
| 2011 FY | 3.62 Billion EUR | -6.21% |
| 2011 Q3 | 4.07 Billion EUR | 8.35% |
| 2011 Q4 | 3.62 Billion EUR | -11.02% |
| 2011 Q2 | 3.76 Billion EUR | 6.06% |
| 2010 Q2 | 3.92 Billion EUR | 18.96% |
| 2010 FY | 3.86 Billion EUR | 32.68% |
| 2010 Q1 | 3.3 Billion EUR | 13.35% |
| 2010 Q4 | 3.86 Billion EUR | -7.0% |
| 2010 Q3 | 4.15 Billion EUR | 5.8% |
| 2009 Q3 | 3.29 Billion EUR | 2.49% |
| 2009 Q4 | 2.91 Billion EUR | -11.62% |
| 2009 Q2 | 3.21 Billion EUR | -3.51% |
| 2009 Q1 | 3.33 Billion EUR | -1.13% |
| 2009 FY | 2.91 Billion EUR | -13.59% |
| 2008 Q2 | 3.84 Billion EUR | 3.62% |
| 2008 FY | 3.37 Billion EUR | 5.09% |
| 2008 Q1 | 3.71 Billion EUR | 15.81% |
| 2008 Q3 | 4.16 Billion EUR | 8.1% |
| 2008 Q4 | 3.37 Billion EUR | -18.99% |
| 2007 Q4 | 3.2 Billion EUR | -14.69% |
| 2007 Q3 | 3.76 Billion EUR | 11.72% |
| 2007 FY | 3.2 Billion EUR | 11.38% |
| 2007 Q1 | 3.1 Billion EUR | 7.92% |
| 2007 Q2 | 3.36 Billion EUR | 8.3% |
| 2006 Q4 | 2.87 Billion EUR | -16.07% |
| 2006 Q3 | 3.43 Billion EUR | -12.3% |
| 2006 Q1 | 3.85 Billion EUR | 10.88% |
| 2006 FY | 2.87 Billion EUR | -17.19% |
| 2006 Q2 | 3.91 Billion EUR | 1.48% |
| 2005 Q1 | 3.6 Billion EUR | 11.79% |
| 2005 FY | 3.47 Billion EUR | 7.76% |
| 2005 Q4 | 3.47 Billion EUR | -13.45% |
| 2005 Q3 | 4.01 Billion EUR | 0.66% |
| 2005 Q2 | 3.99 Billion EUR | 10.64% |
| 2004 Q4 | 3.22 Billion EUR | -20.4% |
| 2004 FY | 3.22 Billion EUR | 0.91% |
| 2004 Q1 | 3.53 Billion EUR | 10.65% |
| 2004 Q2 | 3.73 Billion EUR | 5.53% |
| 2004 Q3 | 4.05 Billion EUR | 8.58% |
| 2003 Q4 | 3.19 Billion EUR | -17.3% |
| 2003 FY | 3.19 Billion EUR | -9.27% |
| 2003 Q3 | 3.86 Billion EUR | 3.6% |
| 2003 Q2 | 3.73 Billion EUR | 0.6% |
| 2003 Q1 | 3.71 Billion EUR | 5.26% |
| 2002 FY | 3.52 Billion EUR | -17.98% |
| 2002 Q1 | 4.44 Billion EUR | 3.5% |
| 2002 Q2 | 4.3 Billion EUR | -3.32% |
| 2002 Q3 | 4.52 Billion EUR | 5.34% |
| 2002 Q4 | 3.52 Billion EUR | -22.18% |
| 2001 FY | 4.29 Billion EUR | -18.82% |
| 2001 Q2 | 5.81 Billion EUR | -1.63% |
| 2001 Q1 | 5.9 Billion EUR | 11.61% |
| 2001 Q3 | 5.51 Billion EUR | -5.19% |
| 2001 Q4 | 4.29 Billion EUR | -22.01% |
| 2000 Q1 | 4.78 Billion EUR | 4.51% |
| 2000 FY | 5.29 Billion EUR | 15.6% |
| 2000 Q2 | 5.13 Billion EUR | 7.29% |
| 2000 Q3 | 5.76 Billion EUR | 12.23% |
| 2000 Q4 | 5.29 Billion EUR | -8.13% |
| 1999 FY | 4.57 Billion EUR | 7.74% |
| 1999 Q2 | 4.94 Billion EUR | 4.57% |
| 1999 Q1 | 4.72 Billion EUR | 11.2% |
| 1999 Q3 | 5.04 Billion EUR | 2.17% |
| 1999 Q4 | 4.57 Billion EUR | -9.31% |
| 1998 Q1 | 5.74 Billion EUR | 12.19% |
| 1998 FY | 4.25 Billion EUR | -17.06% |
| 1998 Q4 | 4.25 Billion EUR | -20.93% |
| 1998 Q3 | 5.37 Billion EUR | 2.29% |
| 1998 Q2 | 5.25 Billion EUR | -8.6% |
| 1997 Q1 | 5.56 Billion EUR | 12.15% |
| 1997 FY | 5.12 Billion EUR | 3.19% |
| 1997 Q4 | 5.12 Billion EUR | -17.54% |
| 1997 Q3 | 6.21 Billion EUR | 5.1% |
| 1997 Q2 | 5.91 Billion EUR | 6.16% |
| 1996 Q4 | 4.96 Billion EUR | 0.0% |
| 1996 FY | 4.96 Billion EUR | -15.61% |
| 1995 FY | 5.88 Billion EUR | 19.95% |
| 1995 Q4 | 5.88 Billion EUR | 0.0% |
| 1994 Q4 | 4.9 Billion EUR | 0.0% |
| 1994 FY | 4.9 Billion EUR | 9.84% |
| 1993 Q4 | 4.46 Billion EUR | 0.0% |
| 1993 FY | 4.46 Billion EUR | -6.48% |
| 1992 Q4 | 4.77 Billion EUR | 0.0% |
| 1992 FY | 4.77 Billion EUR | 4.83% |
| 1991 FY | 4.55 Billion EUR | -8.97% |
| 1991 Q4 | 4.55 Billion EUR | 0.0% |
| 1990 Q4 | 5 Billion EUR | 0.0% |
| 1990 FY | 5 Billion EUR | -11.72% |
| 1989 Q4 | 5.66 Billion EUR | 0.0% |
| 1989 FY | 5.66 Billion EUR | 5.34% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Abbott Laboratories | 6.57 Billion USD | 46.865% |
| Allurion Technologies Inc. | 6.17 Million USD | -56471.058% |
| Artivion, Inc. | 81.97 Million USD | -4158.563% |
| Avanos Medical, Inc. | 163.2 Million USD | -2039.093% |
| Butterfly Network, Inc. | 75.83 Million USD | -4503.294% |
| Butterfly Network, Inc. | 75.83 Million USD | -4503.294% |
| Bio-Rad Laboratories, Inc. | 780.51 Million USD | -347.268% |
| Boston Scientific Corporation | 2.48 Billion USD | -40.539% |
| Perspective Therapeutics, Inc. | 1.4 Million USD | -247664.372% |
| CONMED Corporation | 318.32 Million USD | -996.681% |
| Edwards Lifesciences Corporation | 1.16 Billion USD | -198.836% |
| Paragon 28, Inc. | 98.06 Million USD | -3459.993% |
| Glaukos Corporation | 41.98 Million USD | -8214.676% |
| Globus Medical, Inc. | 848.13 Million USD | -311.609% |
| Inspire Medical Systems, Inc. | 33.88 Million USD | -10202.494% |
| Integer Holdings Corporation | 239.71 Million USD | -1356.307% |
| Medtronic plc | 5.21 Billion USD | 33.084% |
| Nevro Corp. | 118.67 Million USD | -2841.623% |
| Owlet, Inc. | 6.49 Million USD | -53665.594% |
| Penumbra, Inc. | 388.02 Million USD | -799.689% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | -45.762% |
| Sonendo, Inc. | 11.07 Million USD | -31424.291% |
| STERIS plc | 674.53 Million USD | -417.542% |
| Stryker Corporation | 4.84 Billion USD | 27.917% |
| Vapotherm, Inc. | 22.96 Million USD | -15099.408% |
| Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | -46.361% |